tiprankstipranks
Aprea Therapeutics presents preliminary results on APR-1051
PremiumThe FlyAprea Therapeutics presents preliminary results on APR-1051
4M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Aprea Therapeutics reports Q2 EPS (58c) vs. (87c) last year
PremiumThe FlyAprea Therapeutics reports Q2 EPS (58c) vs. (87c) last year
6M ago
Aprea Therapeutics announces first patient dosed in ACESOT-1051 Phase I trial
Premium
The Fly
Aprea Therapeutics announces first patient dosed in ACESOT-1051 Phase I trial
8M ago
Aprea announces SRC enhances dosing of patients with ATRN-119 at 800 mg
Premium
The Fly
Aprea announces SRC enhances dosing of patients with ATRN-119 at 800 mg
9M ago
Aprea Therapeutics price target raised to $11 from $9 at Wedbush
PremiumThe FlyAprea Therapeutics price target raised to $11 from $9 at Wedbush
11M ago
Aprea Therapeutics sees cash runway into 3Q25
Premium
The Fly
Aprea Therapeutics sees cash runway into 3Q25
11M ago
Aprea Therapeutics reports Q4 EPS (92c), consensus (77c)
Premium
The Fly
Aprea Therapeutics reports Q4 EPS (92c), consensus (77c)
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100